Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
Open accessThe DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen into s.c. lymph nodes. The objective was to evaluate safety and efficacy compared with conventional s.c. immunotherapy. In a monocentric open-label trial, 165 patients with grass pollen-induced rhinoconjunctivitis were randomized to receive either 54 s.c. injections with pollen extract over 3 years [cumulative allergen dose 4,031,540 standardized quality units (SQ-U)] or 3 intralymphatic injections over 2 months (cumulative allergen dose 3,000 SQ-U). Patients were evaluated after 4 months, 1 year, and 3 years by nasal provocation, skin prick testing, IgE measurements, and symptom scores. Three low-dose intralymphatic allergen administrations increased tolerance to nasal provocation with pollen already within 4 months ( P < 0.001). Tolerance was long lasting and equivalent to that achievable after standard s.c. immunotherapy ( P = 0.291 after 3 years). Intralymphatic immunotherapy ameliorated hay fever symptoms ( P < 0.001), reduced skin prick test reactivity ( P < 0.001), decreased specific serum IgE ( P < 0.001), caused fewer adverse events than s.c. immunotherapy ( P = 0.001), enhanced compliance ( P < 0.001), and was less painful than venous puncture ( P = 0.018). In conclusion, intralymphatic allergen administration enhanced safety and efficacy of immunotherapy and reduced treatment time from 3 years to 8 weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The major advantages of this route of allergen application are the markedly reduced duration of immunotherapy treatment (both time spent and number of visits) and the much lower amount of allergen required to achieve results.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Clinical trials have illustrated that a reduction in AR symptoms can be achieved with just 3 doses of injected allergen, with a dosage interval of 1 month1716-1720 (Table IX.D.6).”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“In 2008, Senti et al.1716 compared ILIT to SCIT and not to placebo.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Most trials1716,1718-1721 used commercially available grass pollen or birch pollen allergen extract as the antigen.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Of the 6 trials published thus far, 5 have demonstrated clinical efficacy and safety.1716-1720”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
Citations
Cites
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E.-M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A., & Nouri-Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,373
Möller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Position Paper: Allergen standardization and skin tests
Dreborg, S., & Frew, A. (1993) · Allergy · doi:10.1111/j.1398-9995.1993.tb04756.x · Cited by 753
Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
Bousquet, J., Lockey, R., Malling, H. J., Alvarez-Cuesta, E., Canonica, G. W., Chapman, M. D., Creticos, P. J., Dayer, J. M., Durham, S. R., Demoly, P., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63136-5 · Cited by 736
Arbes Jr., S. J., Gergen, P. J., Elliott, L., & Zeldin, D. C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.017 · Cited by 639 · cited 1×
“I allergies, such as allergic rhinoconjunctivitis and asthma, have become highly prevalent, affecting up to 35% of the population in westernized countries (1).”
BackgroundPajno, G. B., Barberio, G., De Luca, F., Morabito, L., & Parmiani, S. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01161.x · Cited by 546
Varney, V. A., Gaga, M., Frew, A. J., Aber, V. R., Kay, A. B., & Durham, S. R. (1991) · BMJ · doi:10.1136/bmj.302.6771.265 · Cited by 384
Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs
Kündig, T. M., Bachmann, M. F., DiPaolo, C., Simard, J. J. L., Battegay, M., Lother, H., Gessner, A., Kühlcke, K., Ohashi, P. S., Hengartner, H., et al. (1995) · Science · doi:10.1126/science.7761853 · Cited by 301
Self-citation(1993) · PubMed · Cited by 221
Research works printed but not linked: 1
- Epidemiology Surveys and Danske Equities (ALK-Abelló, Hørsholm, Denmark, 2005).
Cited by
Items 101–200 of 363
Ludvigsson, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051598 · Cited by 38
Brehler, R., Klimek, L., Kopp, M., & Virchow, J. C., Jr. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0148 · Cited by 49
Vaccination against Allergy: A Paradigm Shift?
Bachmann, M. F., Mohsen, M. O., Kramer, M. F., & Heath, M. D. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.007 · Cited by 42
Jónsdóttir, S., Svansson, V., Stefánsdóttir, S. B., Schüpbach, G., Rhyner, C., Marti, E., & Torsteinsdóttir, S. (2016) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2016.02.017 · Cited by 35
Leitlinie zur (allergen-)spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen
Pfaar, O., Bachert, C., Bufe, A., Buhl, R., Ebner, C., Eng, P. A., Friedrichs, F., Fuchs, T., Hamelmann, E. H., Hartwig-Bade, D., et al. (2014) · Allergo Journal · doi:10.1007/s15007-014-0707-5 · Cited by 45
Peptide allergen‐specific immunotherapy for allergic airway diseases—State of the art
Wraith, D. C., & Krishna, M. T. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.13840 · Cited by 34
Hellkvist, L., Hjalmarsson, E., Weinfeld, D., Dahl, Å. E., Karlsson, A., Westman, M., Lundkvist, K., Winqvist, O., Georén, S. K., Westin, U., et al. (2021) · Allergy · doi:10.1111/all.15042 · Cited by 32
One Century of Allergen-Specific Immunotherapy for Respiratory Allergy
Incorvaia, C., & Frati, F. (2011) · Immunotherapy · doi:10.2217/imt.11.36 · Cited by 31
Novel immunotherapy vaccine development
Jutel, M., & Akdiş, C. A. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000121 · Cited by 32
Allergen-specific intralymphatic immunotherapy in human and animal studies
Kim, S. T., Park, S. H., Lee, S. M., & Lee, S. P. (2017) · Asia Pacific Allergy · doi:10.5415/apallergy.2017.7.3.131 · Cited by 30
Moos, S. C. V., Kündig, T. M., & Senti, G. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.02.012 · Cited by 34
Self-citationFreiberger, S. N., Zehnder, M., Gafvelin, G., Grönlund, H., Kündig, T. M., & Johansen, P. (2016) · Allergy · doi:10.1111/all.12946 · Cited by 32
Self-citationMechanisms of IgE-mediated allergy
Rindsjö, E., & Scheynius, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.038 · Cited by 30
Allergen immunotherapy: a history of the first 100 years
Fitzhugh, D. J., & Lockey, R. F. (2011) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32834c3134 · Cited by 32
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs
Klimek, L., Bachmann, M. F., Senti, G., & Kündig, T. M. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.924854 · Cited by 28
Self-citationAllergen Immunotherapy, Routes of Administration and Cytokine Networks: an Update
Cuppari, C., Leonardi, S., Manti, S., Filippelli, M., Alterio, T., Spicuzza, L., Rigoli, L. C., Arrigo, T., Lougaris, V., & Salpietro, C. D. (2014) · Immunotherapy · doi:10.2217/imt.14.47 · Cited by 32
Tavira, B., Barcenilla, H., Wahlberg, J., Achenbach, P., Ludvigsson, J., & Casas, R. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9391845 · Cited by 29
Wang, K., Zheng, R., Chen, Y., Yu, Q., Zhong, H., Xiao, P., Wang, Y., & Tang, J. (2019) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2019.102280 · Cited by 29
Intralymphatic immunotherapy for mountain cedar pollinosis
Thompson, C. P., Silvers, S. K., & Shapiro, M. A. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.04.030 · Cited by 28
Park, H. J., Kim, S., Shin, Y. S., Park, C. H., Cho, E., Choi, S. J., Park, S. H., Jung, J. H., Kang, I. G., Lee, M. S., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01766-0 · Cited by 30
Allergic rhinitis: current options and future perspectives
Braido, F., Arcadipane, F., Marugo, F., Hayashi, M., & Pawankar, R. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000043 · Cited by 33
Novel routes for Allergen Immunotherapy: Safety, Efficacy and Mode of Action
Moingeon, P. E., & Mascarell, L. (2012) · Immunotherapy · doi:10.2217/imt.11.171 · Cited by 34
Sestak, J. O., Fakhari, A., Badawi, A. H., Siahaan, T. J., & Berkland, C. J. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9654-z · Cited by 31
Investigational new drugs for allergic rhinitis
Ricketti, P. A., Alandijani, S. A., Lin, C. H., & Casale, T. B. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1290079 · Cited by 29
Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis
Worm, M., Patel, D., & Creticos, P. S. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.827661 · Cited by 28
Novel strategies in immunotherapy for allergic diseases
Rajakulendran, M., Tham, E. H., Soh, J. Y., & Bever, H. P. V. (2018) · Asia Pacific Allergy · doi:10.5415/apallergy.2018.8.e14 · Cited by 30
Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination
McCright, J., & Maisel, K. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1695476 · Cited by 28
Sustained effects of intralymphatic pollen-specific immunotherapy on Japanese cedar pollinosis
Terada, T., Omura, S., Kikuoka, Y., Suzuki, M., Inaka, Y., Inui, T., Matsuda, M., Nabe, T., & Kawata, R. (2020) · Rhinology Journal · doi:10.4193/rhin19.301 · Cited by 27
Pharmacotherapy of allergic rhinitis: current options and future perspectives
Ridolo, E., Montagni, M., Melli, V., Braido, F., Incorvaia, C., & Canonica, G. W. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.860445 · Cited by 30
Long‐term effects of intralymphatic immunotherapy ( ILIT ) on canine atopic dermatitis
Timm, K., Mueller, R. S., & Nett, C. (2018) · Veterinary Dermatology · doi:10.1111/vde.12517 · Cited by 84
Immunotherapy for allergies and asthma: present and future
Mohapatra, S. S., Qazi, M., & Hellermann, G. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.05.012 · Cited by 32
Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis
Werner, M. T., & Bosso, J. V. (2021) · Allergy and Asthma Proceedings · doi:10.2500/aap.2021.42.210028 · Cited by 26
Aini, N. R., Norhayati, M. N., Daud, M. K. M., Wise, S. K., & Abdullah, B. (2021) · Clinical and Translational Allergy · doi:10.1002/clt2.12055 · Cited by 27
Mechanisms and Biomarkers of Successful Allergen-Specific Immunotherapy
López, J.-F., Bel Imam, M., Satitsuksanoa, P., Lems, S., Yang, M., Hwang, Y.-K., Losol, P., Choi, J.-P., Kim, S.-H., Chang, Y.-S., et al. (2022) · Asia Pacific Allergy · doi:10.5415/apallergy.2022.12.e45 · Cited by 25
Intralymphatic allergen immunotherapy against pollen allergy
Ahlbeck, L., Ahlberg, E., Nyström, U., Björkander, J., & Jenmalm, M. C. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.07.010 · Cited by 27
Emerging therapies in allergic conjunctivitis and dry eye syndrome
Nye, M., Rudner, S., & Bielory, L. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.802773 · Cited by 28
Antigen-Specific Immunotherapy against Allergic Rhinitis: The State of the Art
Fujimura, T., & Okamoto, Y. (2010) · Allergology International · doi:10.2332/allergolint.09-rai-0151 · Cited by 25
New treatments for allergen immunotherapy
Akdis, M. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-23 · Cited by 31
[Mexican clinical practice guidelines of immunotherapy 2011].
Larenas‐Linnemann, D. E., Ortega‐Martell, J. A., Del-Rio-Navarro, B. E., Rodríguez‐Pérez, N., Arias‐Cruz, A., Estrada, A., Becerril-Ángeles, M., Pietropaolo-Cienfuegos, D. R., Ambriz-Moreno, M. D. J., Báez-Loyola, C., et al. (2011) · PubMed · Cited by 26
Musarra, A., Bignardi, D., Troise, C., & Passalacqua, G. (2010) · PubMed · Cited by 24
López‐Santalla, M., Mancheño‐Corvo, P., Escolano, A., Menta, R., DelaRosa, O., Abad, J. L., Büscher, D., Redondo, J. M., Bueren, J. A., Dalemans, W., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00638 · Cited by 25
New Therapies for Allergic Rhinitis
Braido, F., Sclifò, F., Ferrando, M., & Canonica, G. W. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0422-z · Cited by 27
Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen
Grönlund, H., & Gafvelin, G. (2010) · Human Vaccines · doi:10.4161/hv.6.12.13348 · Cited by 28
Mancheño‐Corvo, P., López‐Santalla, M., Menta, R., DelaRosa, O., Mulero, F., del Río, B., Ramirez, C., Büscher, D., Bueren, J. A., López-Belmonte, J. L., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00462 · Cited by 24
Weinfeld, D., Westin, U., Hellkvist, L., Mellqvist, U., Jacobsson, I., & Cardell, L. (2020) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-020-00427-z · Cited by 25
Intralymphatic immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis
Hoang, M. P., Seresirikachorn, K., Chitsuthipakorn, W., & Snidvongs, K. (2021) · Rhinology Journal · doi:10.4193/rhin20.572 · Cited by 26
Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity
Richardson, N., & Wraith, D. C. (2021) · Immunotherapy Advances · doi:10.1093/immadv/ltab009 · Cited by 25
Clinical outcome measures of specific immunotherapy
Pfaar, O., Anders, C., & Klimek, L. (2009) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32832aef57 · Cited by 23
Zhang, J., Yang, X., Chen, G., Hu, J., He, Y., Ma, J., Ma, Z., Chen, H., Huang, Y., Wu, Q., et al. (2023) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2023.10.029 · Cited by 25
Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy
Crameri, R., Kündig, T. M., & Akdiş, C. A. (2009) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283310fdf · Cited by 22
Self-citationEmerging drugs for allergic conjunctivitis
Ridolo, E., Montagni, M., Caminati, M., Senna, G., Incorvaia, C., & Canonica, G. W. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.902443 · Cited by 23
Batard, T., Canonica, G. W., Pfaar, O., Shamji, M. H., O’Hehir, R. E., van Zelm, M. C., & Mascarell, L. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.02.004 · Cited by 23
Klimek, L., Schendzielorz, P., Mueller, P., Saudan, P., & Willers, J. (2013) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2013.27.3875 · Cited by 23
Honeybee Venom Immunotherapy: Certainties and pitfalls
Bilò, M. B., Antonicelli, L., & Bonifazi, F. (2012) · Immunotherapy · doi:10.2217/imt.12.113 · Cited by 22
Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials
Senti, G., Freiburghaus, A. U., & Kündig, T. M. (2010) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32833f1419 · Cited by 22
Self-citationMueller, R. S. (2023) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.22.12.0576 · Cited by 26
Antigen-based immunotherapy (AIT) for autoimmune and allergic disease
MacLeod, M. K. L., & Anderton, S. M. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.05.003 · Cited by 22
A comparison of immunotherapy delivery methods for allergen immunotherapy
Klimek, L., & Pfaar, O. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.13.25 · Cited by 22
Is Clinical Tolerance Possible after Allergen Immunotherapy?
Moran, T. P., & Burks, A. W. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0523-3 · Cited by 24
Allergy vaccines: dreams and reality
Crameri, R. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.6.991 · Cited by 21
Self-citationDesign and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines
Song, K., & Pun, S. H. (2024) · BME Frontiers · doi:10.34133/bmef.0038 · Cited by 20
Modified Allergens and their Potential to Treat Allergic Disease
Zuidmeer, L., & van Ree, R. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0478-9 · Cited by 21
Nanoscience versus Viruses: The SARS‐CoV‐2 Case
Gościańska, J., Freund, R., & Wuttke, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107826 · Cited by 21
History of Immunotherapy: The First 100 Years
Fitzhugh, D. J., & Lockey, R. F. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.03.003 · Cited by 20
New drugs in early-stage clinical trials for allergic rhinitis
Heffler, E. M., Brussino, L., Giacco, S. D., Paoletti, G., Minciullo, P. L., Varricchi, G., Scadding, G. W., Malvezzi, L., VIRGILIO, A. D., Spriano, G., et al. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1571581 · Cited by 24
Recent Advances in Allergen-Specific Immunotherapy in Humans: A Systematic Review
Lee, S. P., Shin, Y. S., Kang, S., Kim, T., & Lee, S. M. (2022) · Immune Network · doi:10.4110/in.2022.22.e12 · Cited by 20
Food Allergy Diagnosis and Therapy: Where are we Now?
Syed, A., Kohli, A., & Nadeau, K. C. (2013) · Immunotherapy · doi:10.2217/imt.13.93 · Cited by 22
Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases
Cox, L. (2020) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2020.06.008 · Cited by 22
Tissue‐Targeted Drug Delivery Strategies to Promote Antigen‐Specific Immune Tolerance
Rui, Y., Eppler, H. B., Yanes, A. A., & Jewell, C. M. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202238 · Cited by 19
Ahlbeck, L., Ahlberg, E., Stuivers, L., Björkander, J., Nyström, U., Retsas, P., Govindaraj, D., Jenmalm, M. C., & Duchén, K. (2023) · Clinical & Experimental Allergy · doi:10.1111/cea.14307 · Cited by 19
Wang, Q., Wang, K., Qin, Y., Huang, W., Li, Y., Yu, Q., Xiong, Y., Guo, Y., Zheng, R., & Tang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1144813 · Cited by 21
Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective
Pfaar, O., Portnoy, J. M., Nolte, H., Chaker, A. M., Luna-Pech, J. A., Patterson, A. M., Pandya, A., & Larenas‐Linnemann, D. E. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.08.047 · Cited by 19
Novel treatments of asthma and allergic diseases
Chini, L., Monteferrario, E., Graziani, S., & Moschese, V. (2013) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2013.10.007 · Cited by 19
Intralymphatic Immunotherapy and Vaccination in Mice
Johansen, P., & Kündig, T. M. (2014) · Journal of Visualized Experiments · doi:10.3791/51031 · Cited by 18
Self-citationNicolas, C. T., Kaiser, R. A., Hickey, R., Allen, K. L., Du, Z., VanLith, C. J., Guthman, R. M., Amiot, B. P., Suksanpaisan, L., Han, B., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.07.009 · Cited by 19
Ahlbeck, L., Ahlberg, E., Björkander, J., Aldén, C., Papapavlou, G., Palmberg, L., Nyström, U., Retsas, P., Nordenfelt, P., Togö, T., et al. (2022) · Clinical & Experimental Allergy · doi:10.1111/cea.14138 · Cited by 18
Self-citationNovel immunotherapeutic approaches for allergy and asthma
O’Mahony, L., Akdiş, M., Crameri, R., & Akdiş, C. A. (2010) · Autoimmunity · doi:10.3109/08916931003674725 · Cited by 18
Self-citationBioresorbable polymer microparticles in the medical and pharmaceutical fields
Chew, S. A., Hinojosa, V. A., & Arriaga, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100262-9.00011-2 · Cited by 21
Novel strategies for the treatment of grass pollen-induced allergic rhinitis
Larsson, O., Hellkvist, L., Peterson-Westin, U., & Cardell, L. O. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1190829 · Cited by 16
Evolving paradigms of treatment of allergic and nonallergic rhinitis
Rackerby, N., Ahn, C., Ball, B. D., Samant, S. A., Bernstein, J. S., & Bernstein, J. A. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.04.003 · Cited by 20
Chabot, A., Senti, G., Erdmann, I., Prinz, B., Wüthrich, B., Šošić, L., Kündig, T. M., & Johansen, P. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.832010 · Cited by 16
Self-citationAllergen immunotherapy: routes, safety,efficacy, and mode of action
Ponda, P., & Hochfelder (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s31467 · Cited by 18
Strengthening the case for intralymphatic immunotherapy
Hoffmann, H. J., & Hviid‐Vyff, B. (2022) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000857 · Cited by 15
Arguing the Misconceptions in Allergen-Specific Immunotherapy
Ridolo, E., Montagni, M., Bonzano, L., Senna, G., & Incorvaia, C. (2014) · Immunotherapy · doi:10.2217/imt.14.23 · Cited by 14
Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
Lourenço, E. A., Caldeira, E. J., Carvalho, C., da Cunha, M. R., de Carvalho, M. V. H., & Passos, S. D. (2015) · International Archives of Otorhinolaryngology · doi:10.1055/s-0035-1564437 · Cited by 14
Gutermuth, J., Grosber, M., Pfaar, O., Bergmann, K., & Ring, J. (2022) · Allergologie select · doi:10.5414/alx02330e · Cited by 17
Alternative Products to Treat Allergic Rhinitis and Alternative Routes for Allergy Immunotherapy
İpçi, K., Öktemer, T., Muluk, N. B., Şahin, E., Altıntoprak, N., Bafaqeeh, S. A., Kurt, Y. T., Mladina, R., Šubarić, M., & Cingi, C. (2016) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2016.30.4364 · Cited by 14
Turkish Guidelines for Diagnosis and Treatment of Allergic Rhinitis (ART)
Ecevit, M. C., Özcan, M., Can, İ. H., Tatar, E. Ç., Özer, S., Esen, E., Atan, D., Göde, S., Elsürer, Ç., Eryılmaz, A., et al. (2021) · Turkish Archives of Otorhinolaryngology · doi:10.4274/tao.2021.suppl.1 · Cited by 23
New Routes of Allergen Immunotherapy
Arıcıgil, M., Muluk, N. B., Sakarya, E. U., Şakalar, E., Şentürk, M., Reisacher, W. R., & Cingi, C. (2016) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2016.30.4379 · Cited by 15
Flory, S., Hviid‐Vyff, B., Šošić, L., Schmid, J. M., Ahlbeck, L., Widmer, E. C. J., Lang, C. C. V., Ikenberg, K., Kündig, T. M., Hoffmann, H. J., et al. (2024) · Allergy · doi:10.1111/all.16138 · Cited by 13
Self-citationAllergen Immunotherapy: A Centenary Celebration
Durham, S. R., & Nelson, H. S. (2011) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3182218920 · Cited by 15
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy
Filì, L., Vultaggio, A., Cardilicchia, E., Manuelli, C., Casini, A., Nencini, F., Maggi, L., Pratesi, S., Petroni, G., Boscaro, F., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.030 · Cited by 13
Mucci, T., Govindaraj, S., & Tversky, J. (2011) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20287 · Cited by 12
Mueller, R. S., Zablotski, Y., Baumann, K. N., Boehm, T. M. S. A., Kasper, B., Klinger, C. J., Monke, M., Udraite, L., Weitzer, T., & Gedon, N. K. Y. (2022) · Veterinary Dermatology · doi:10.1111/vde.13138 · Cited by 14
Jiang, S., Xie, S., Tang, Q., Zhang, H., Xie, Z., Zhang, J., & Jiang, W. (2023) · Mediators of Inflammation · doi:10.1155/2023/9377518 · Cited by 13
Klimek, L., Willers, J., Schendzielorz, P., Kündig, T. M., & Senti, G. (2013) · HNO · doi:10.1007/s00106-013-2761-9 · Cited by 12
Self-citationThe role of immunotherapy in the management of childhood asthma
Hedlin, G., & van Hage, M. (2012) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465812439793 · Cited by 42
Personalized therapies for the treatment of allergic rhinitis
Licari, A., Castagnoli, R., Tosca, M. A., Marseglia, G. L., & Ciprandi, G. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1681896 · Cited by 12
Injection Immunotherapy for Inhalant Allergens
Nelson, H. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00088-7 · Cited by 13
Costimulation Immunotherapy in Allergies and Asthma
Mir, M. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802585-7.00004-2 · Cited by 12
Metadata
- Authors
- Senti, G., Prinz Vavricka, B. M., Erdmann, I., Diaz, M. I., Markus, R., McCormack, S. J., Simard, J. J., Wüthrich, B., Crameri, R., Graf, N., Johansen, P., & Kündig, T. M.
- Affiliations
- University Hospital Zurich (CH)
- Unit for Experimental Immunotherapy, Department of Dermatology, and
- MannKind Corporation (United States) (US)
- Swiss Institute for Asthma and Allergy Research, 7270 Davos, Switzerland
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-11-18
- Volume
- 105
- Issue
- 46
- Pages
- 17908-17912
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2582048
- OpenAlex
- W1975755712
- Cited by
- 364
- References
- 26
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 14 · 2023: 22 · 2022: 26 · 2021: 18 · 2020: 21 · 2019: 12 · 2018: 18 · 2017: 23 · 2016: 24 · 2015: 19 · 2014: 35 · 2013: 30 · 2012: 26
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114634, 310000)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, subcutaneous immunotherapy, grass pollen allergy, rhinoconjunctivitis, allergic rhinitis, IgE-mediated allergy, lymph node injection, treatment duration, treatment safety, medication adherence
- MeSH terms
- Adolescent, Adult, Aged, Allergens, Desensitization, Immunologic, Female, Humans, Hypersensitivity, Immunoglobulin E, Immune Tolerance, Injections, Intralymphatic, Injections, Subcutaneous, Male, Middle Aged, Pain, Skin Tests, Time Factors, Treatment Outcome, Anti-Allergic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.